What is PatientWing?
Operating under the legal entity VitalTrax, LLC, PatientWing serves as a critical bridge between pharmaceutical sponsors and clinical research sites. The company addresses the high-friction environment of clinical trial recruitment by deploying a multifaceted platform that integrates digital outreach, precision trial matching, and concierge-level navigation services. Its focus on complex therapeutic areas, including oncology and rare diseases, positions the company as a vital partner in accelerating the drug development lifecycle. By streamlining the patient journey, PatientWing effectively reduces the time-to-market for life-saving therapies, establishing a robust competitive moat in the digital health sector.
How much funding has PatientWing raised?
PatientWing has raised a total of $150K across 1 funding round:
Angel/Seed
$150K
Angel/Seed (2017): $150K with participation from Safeguard Scientifics
Key Investors in PatientWing
Safeguard Scientifics
A venture capital firm focused on providing growth capital and operational support to technology-driven healthcare and life sciences companies.
What's next for PatientWing?
With this recent strategic investment, PatientWing is well-positioned to expand its operational footprint and enhance its technological capabilities. The company is expected to prioritize the scaling of its patient matching algorithms and the deepening of its integration with global research networks. As the clinical trial landscape becomes increasingly decentralized, PatientWing's ability to provide high-touch, data-driven recruitment solutions will likely serve as a primary driver for future growth. The firm's trajectory suggests a focus on long-term sustainability and the potential for further market penetration in the high-stakes pharmaceutical research industry.
See full PatientWing company page
